Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Progenics snags FDA nod for $300K ‘ultra-orphan’ cancer-fighter Azedra

fiercepharmaAugust 01, 2018

Tag: Azedra , ultra-orphan

PharmaSources Customer Service